Non-steroid Anti-inflammatory Drugs

Non-steroid Anti-inflammatory Drugs

Non-steroid Anti-inflammatory Drugs

• • These are medicinal drugs that function similarly to steroids and are frequently used to treat fever and pain.
  • For example, people take them to get immediate relief from headaches, aches, fever, dental pain, cramps during menstruation, swelling, etc. 
  • These medications include, but are not limited to, aspirin, ibuprofen, and nemesulide. 
  • The DTAB outlawed two NSAIDs but gave no guidance regarding the use of a third non-steroid anti-inflammatory medication. 
  • The DTAB has recommended the formation of a committee in response to the negative effects on the environment and animal health. 
  • The committee will compile a list of these dangerous drugs. 

Other Details

Ban

• • The DTAB proposed, at its 89th meeting, to outlaw the production, marketing, and distribution of two NSAIDs: ketoprofen and aceclofenac. 
  • These two medications are widely used in the treatment of livestock; however, DTAB has not issued any recommendations regarding Nimesulide, an NSAID that is similar to it and just as harmful to vultures.
    

Need for Ban

• • It is estimated that the widespread and unchecked use of NSAIDs is to blame for a volumetric change in vulture population, from 4 crores to just 19,000, as well as the detrimental effects these medications have on vultures’ health and well-being and conservation efforts.
    

Benefits of Vultures for Environment

• • It will increase the number of vultures, which are scavengers that clean up and enhance the health of the ecosystem by consuming the bodies of dead animals.
  • It can also effectively control infection in our ecosystem. 
  • They also aid in reducing the possibility of water contamination from dead animals near bodies of water, which helps to lessen the spread of disease. 

Drugs Technical Advisory Board (DTAB)

• • The Drugs and Cosmetics Act of 1940 established this statutory body, which reports to the Ministry of Health and Family Welfare and advises the Union and state governments on technical issues related to the administration of the Act. 
  • It also makes policy recommendations and offers advice on technical drug-related issues in India.